Driven by Kimmtrak® approval, promising development pipeline and encouraging clinical trial results, the TCR- based therapy market is anticipated to witness significant growth in the mid to long-term. The financial opportunity within the TCR-based therapy market has been analyzed across the following segments:
- Target Indication(s)
- Nasopharyngeal Carcinoma
- Multiple Myeloma
- Head and Neck Carcinoma
- Sarcoma, Melanoma
- Acute Myeloid Leukemia
- Lung Cancer
- Ovarian Cancer
- Merkel Cell Cancer
- Target Antigen
- NY-ESO-1
- EBV
- gp100
- Others
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
The Global TCR Therapy Market (2nd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
- Adaptimmune Therapeutics
- Alaunos Therapeutics
- Bristol Myers Squibb
- Cellular Biomedicine Group
- Gilead Sciences
- GlaxoSmithKline
- Immatics
- Immunocore
- Lion TCR
- Takara Bio
- Zelluna Immunotherapy
Table of Contents
- Preface
- Executive Summary
- Introduction
- TCR Therapies: Market Landscape
- Popular Target Antigen Analysis
- Clinical Trial Analysis
- Key Opinion Leaders
- TCR-based Therapy Profiles
- Partnerships And Collaborations
- Funding And Investment Analysis
- Patent Analysis
- Case Study: Cell Therapy Manufacturing
- Cost Price Analysis
- Market Forecast and Opportunity Analysis
- Promotional Analysis
- Company Profiles
- Concluding Remarks
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market |
You may also like to learn what our experts are sharing in Roots educational series:
Patient Recruitment – Key Determinant of Successful Clinical Trials |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091